Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Jun-24 4:10 PM View:  | Novavax, Inc. (NVAX) | 12-Jun-24 | Option Exercise | 6,670 | -- | -- | 18% 37.25K to 43.92K | |
| 13-Jun-24 5:39 PM View: | Maxcyte, Inc. (MXCT) | 11-Jun-24 | Grant | 21,367 | -- | -- | 21% 100.0K to 121.37K | |
| 13-Jun-23 4:44 PM View: | Novavax, Inc. (NVAX) | 10-Jun-23 | Option Exercise | 3,100 | -- | -- | 9% 34.15K to 37.25K | |
| 30-Mar-23 9:11 AM View: | Maxcyte, Inc. (MXCT) | 29-Mar-23 | Purchase | 80,000 | $4.32 | $345,480.00 | 400% 20.0K to 100.0K | |
| 21-Jun-22 8:46 PM View: | Novavax, Inc. (NVAX) | 17-Jun-22 | Option Exercise | 700 | -- | -- | 2% 33.45K to 34.15K | |
| 15-Dec-21 5:22 PM View: | Novavax, Inc. (NVAX) | 13-Dec-21 | Option Exercise | 1,500 | $25.60 | $38,400.00 | 5% 31.95K to 33.45K | |
| 23-Nov-21 7:46 AM View: | Maxcyte, Inc. (MXCT) | 22-Nov-21 | Purchase | 20,000 | $11.12 | $222,400.00 | 100% 0 to 20.0K | |
| 29-Jun-21 5:13 PM View: | Novavax, Inc. (NVAX) | 25-Jun-21 | Option Exercise | 3,450 | -- | -- | 12% 28.5K to 31.95K | |
| 05-Jan-21 5:42 PM View: | Novavax, Inc. (NVAX) | 31-Dec-20 | Option Exercise | 1,000 | $50.00 | $50,000.00 | 4% 27.5K to 28.5K | |
| 17-Mar-20 4:38 PM View: | Aldeyra Therapeutics, Inc. (ALDX) | 16-Mar-20 | Market Purchase | 40,000 | $2.75 | $110,000.00 | 47% 85.0K to 125.0K | 173% |
| 17-Sep-19 7:36 AM View: | Aldeyra Therapeutics, Inc. (ALDX) | 13-Sep-19 | Market Purchase | 5,000 | $6.00 | $30,000.00 | 6% 80.0K to 85.0K | 25% |
| 13-Sep-19 7:54 AM View: | Aldeyra Therapeutics, Inc. (ALDX) | 12-Sep-19 | Market Purchase | 10,000 | $6.03 | $60,276.00 | 14% 70.0K to 80.0K | 24% |
| 13-Sep-19 7:54 AM View: | Aldeyra Therapeutics, Inc. (ALDX) | 11-Sep-19 | Market Purchase | 10,000 | $5.75 | $57,529.00 | 17% 60.0K to 70.0K | 30% |
| 11-Sep-19 4:05 PM View: | Aldeyra Therapeutics, Inc. (ALDX) | 10-Sep-19 | Market Purchase | 10,000 | $5.09 | $50,857.00 | 20% 50.0K to 60.0K | 47% |
| 11-Sep-19 4:05 PM View: | Aldeyra Therapeutics, Inc. (ALDX) | 09-Sep-19 | Market Purchase | 10,000 | $4.91 | $49,106.00 | 25% 40.0K to 50.0K | 53% |
| 12-May-17 9:59 AM View: | Novavax, Inc. (NVAX) | 11-May-17 | Market Purchase | 200,000 | $0.93 | $185,780.00 | 57% 350.0K to 550.0K | 106% |
| 21-Feb-17 4:33 PM View: | Aldeyra Therapeutics, Inc. (ALDX) | 17-Feb-17 | Private Purchase | 40,000 | $4.50 | $180,000.00 | 100% 0 to 40.0K | |
| 22-Sep-16 4:26 PM View: | Novavax, Inc. (NVAX) | 21-Sep-16 | Market Purchase | 100,000 | $1.72 | $172,010.00 | 40% 250.0K to 350.0K | 11% |
| 25-Mar-14 2:30 PM View: | Novavax, Inc. (NVAX) | 25-Mar-14 | Market Purchase | 50,000 | $4.33 | $216,700.00 | 25% 200.0K to 250.0K | (71%) |
| 13-Jun-13 7:09 AM View: | Novavax, Inc. (NVAX) | 12-Jun-13 | Market Purchase | 50,000 | $1.90 | $95,000.00 | 33% 150.0K to 200.0K | (34%) |
| 11-Apr-12 9:49 AM View: | Novavax, Inc. (NVAX) | 10-Apr-12 | Market Purchase | 50,000 | $1.21 | $60,500.00 | 33% 150.0K to 200.0K | 4% |
| 11-Aug-11 9:06 AM View: | Novavax, Inc. (NVAX) | 09-Aug-11 | Market Purchase | 50,000 | $1.20 | $60,000.00 | 100% 0 to 50.0K | 5% |
| 21-Jun-11 9:08 AM View: | Novavax, Inc. (NVAX) | 20-Jun-11 | Market Purchase | 50,000 | $2.04 | $101,750.00 | 100% 0 to 50.0K | (38%) |
| 07-Aug-08 6:11 PM View: | Intercell Usa, Inc. (IOMID) | 05-Aug-08 | Disposition | 3,461 | $6.60 | $22,842.60 | (100%) 3.46K to 0 | < 1% |